Arialys Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Arialys Therapeutics?

Arialys Therapeutics has 5 investors including MPM Capital And Johnson & Johnson Innovation.

Q: How much funding has Arialys Therapeutics raised to date?

Arialys Therapeutics has raised obfuscated.

Overview

Arialys Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Arialys Therapeutics

CB Rank

26171

Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.

Founded

obfuscation

Private

Venture - Series Unknown

La Jolla, California, United States

11-50

www.arialysrx.com

Health Care

Medical

Neuroscience

Therapeutics

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Mitsuyuki Matsumoto: Scientific Founder and Chief Scientific Officer

Details

Legal Name

Arialys Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Mitsuyuki Matsumoto

About the Company

Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience. The company focuses on how the immune system impacts CNS health, disease, and treatment.

Predictions & Insights

Growth Insight

See this Growth Insight

Arialys Therapeutics is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

ART5803

A clinical-stage therapeutic antibody designed to block pathogenic autoantibodies targeting NMDA receptors in the brain, aiming to restore receptor function and treat autoimmune neuropsychiatric diseases.

Research & Development

Arialys Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Arialys Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
MPM Capital	—	Seed Round - Arialys Therapeutics	—
MPM Capital	—	Seed Round - Arialys Therapeutics	—
MPM Capital	—	Seed Round - Arialys Therapeutics	—
MPM Capital	—	Seed Round - Arialys Therapeutics	—
MPM Capital	—	Seed Round - Arialys Therapeutics	—